046310.KQ Hanall Biopharma Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg's Top 50
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
10:59
May 21
Hanall Biopharma clinical success with J&J.
Hanall Biopharma's positive phase results for a rheumatoid arthritis treatment in collaboration with Johnson & Johnson (Janssen) triggered a limit-up and points to significant upside.
HIGH

About 046310.KQ Analyst Coverage

Buzzberg tracks 046310.KQ (Hanall Biopharma) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.